General experimental procedures Unless otherwise stated, NDA, all starting materials and reagents, such as anhydrous DMF, dichloromethane (DCM), triethylamine (Et 3 N), and human serum, were obtained commercially.
1 H and 13 C NMR spectra were collected in CDCl 3 and DMSO-d 6 solutions using a Bruker AM-300 spectrometer with tetramethylsilane (TMS) as the internal standard. Mass spectra were measured in electrospray ionization (ESI) or matrix-assisted laser desorption/ionization (MALDI) mode. UV/Vis spectra were obtained using a Scinco 3000 spectrophotometer (1 cm quartz cell) at 25°C. Fluorescence spectra were recorded on an RF-5301/PC (Shimada) fluorescence spectrophotometer (1 cm quartz cell) at 25°C. Deionized water was used to prepare all aqueous solutions.
1
H and 2D NMR spectral data were recorded in DMSO-d 6 solution containing Me 4 Si as an internal standard on a Varian Inova 500 MHz spectrometer.
13 C NMR spectra were acquired on a Bruker Avance III 300 (75 MHz) spectrometer. Low-resolution LC/MS data were collected using a Hewlett-Packard series 1100 LC/MS system with a reversed-phase C18 column (Phenomenex Luna, 4.6 mm × 100 mm, 5 µm) at a flow rate of 0.7 mL/min. The crude extract (200 mg) was purified by reversed-phase HPLC (Phenomenex Luna C-18(2), 250 × 100 mm, 2.0 mL/min, 5 µm, 100 Å, UV = 254 nm) using a isocratic solvent system (40% CH 3 CN [0.01% trifluoroacetic acid (TFA)]) to afford 8.0 mg of oil.The pseudo-first-order rate constant (Kobs) of the reaction between probes and thiols was calculated by fitting the fluorescence intensity data in the following equation: Ln(F max − F t ) = Ln F max − K obs t.The quantum yield was determined according to the reported reference (Chen et al, Chem. Commun., 2017, 53, 4791) Study design, patients, and clinical setting
We used the data from a retrospective cohort study of prospectively collected samples from the medical ICU (MICU) of Severance Hospital, a 2000-bed (30-bed MICU) university tertiary referral hospital in Seoul, South Korea. The study included 15 healthy volunteers and 97 consecutive patients aged >19 years who had been admitted to the MICU because of sepsis between March 2015 and August 2015, for a total of 112 participants. According to the 2016 revised sepsis definition (Sepsis-3), sepsis is defined as when patients have suspected infection and a SOFA score ≥ 2 points. 1 All patients presenting with sepsis were treated according to the guidelines of the Surviving Sepsis Campaign. 2 The study protocol was submitted as an ICU cohort and approved by the Institutional Review Board (IRB) of Severance Hospital (IRB number: 4-2013-0585) . In addition, this study was performed in compliance with the principles set forth in the Declaration of Helsinki. 
Clinical data and blood sample collection
Data from all of the patients admitted to the MICU were collected from hospital electronic medical records and blood samples. The severity of each patient's condition was classified according to two different scoring systems. The SOFA and APACHE II scores were calculated. Clinical parameters, such as the blood culture positivity, 28-day mortality, and other demographic characteristic data, were evaluated. Blood samples were collected in tubes containing ethylenediaminetetraacetic acid (EDTA) within 24 hours after admission to the MICU. Simultaneously, we determined the C-reactive protein (CRP), procalcitonin, creatinine, and albumin levels; blood culture results; white blood cell and platelet counts; and APACHE II and SOFA scores. Plasma was prepared by centrifugation for 15 minutes at 800 × g and 4ºC.
Supernatants from centrifuged blood were immediately aliquoted and stored at -80ºC until analysis. The levels of cytokines (IL-1β, IL-10, IL-18, IL-6, TNF-α, and interferon gamma induced protein [IP]-10) were measured using a Human Magnetic Luminex® Screening Assay kit (R&D Systems, Inc., Minneapolis, MN, USA) and performed according to the manufacturer's protocols. All samples and standards were assayed in duplicate using a Luminex 200TM System (Merck Millipore, Darmstadt, Germany).
Measurement of the GSH level in blood samples by NDA and FNDA Collected blood samples were diluted to 10% solutions in HEPES (10 mM, pH = 7.4) buffer. The diluted samples were reacted with 40 μM NDA or 20 μM FNDA at room temperature for 15 minutes, and the fluorescence intensity of each solution was read using a fluorescence spectrometer.
Statistical analysis
Data are described as medians with IQRs. The chi-squared and Fisher's exact tests or the Mann-Whitney U test was used to assess differences between two groups. Pearson correlation analyses were performed to estimate associations between the biomarkers and the APACHE II or SOFA score. AUC analyses of the receiver operating characteristic (ROC) curves were performed to compare the GSH level and APACHE II and SOFA scores. In all cases, a p-value of < 0.05 was considered to be statistically significant. SPSS version 20 (IBM, Armonk, NY, USA) was used for the statistical analysis.
Measurement of two-photon cross section. The two-photon cross section (δ) was determined by using femto second (fs) fluorescence measurement technique as described(S. K. Lee, W. J. Wang, J. J. Choi, C. H. Kim, S. J. Jeon,B. R. Cho, Org. Lett. 2005, 7, 323-326.) . MNDAwere dissolved in 30 mM HEPES buffer (pH 7.4) at concentrations of 1.0 × 10 -5 M and then the two-photon induced fluorescence intensity was measured at 720−980 nm by using Rhodamine 6G as the reference, whose two-photon property has been well characterized in the literature(N. S. Makarov, M.Drobizhev, A. Rebane, Opt. Express 2008, 16, 4029-4047.) . To measure the two-photon cross section (δ) of the reaction product between MNDA (1.0 × 10 -5 M)
and GSH (100 μM), the reaction mixture was kept at RT for 1hrs before the measurement was conducted. The intensities of the two-photon induced fluorescence spectra of the reference and sample emitted at the same excitation wavelength were determined. The TPA cross section was calculated by using δ = δ r (S s Ф r φ r c r )/(S r Ф s φ s c s ): where the subscripts s and r stand for the sample and reference molecules. The intensity of the signal collected by a CCD detector was denoted as S. Φ is the fluorescence quantum yield. φ is the overall fluorescence collection efficiency of the experimental apparatus. The number density of the molecules in solution was denoted as c. δ r is the TPA cross section of the reference molecule.
Two-photon fluorescence microscopy. Two-photon fluorescence microscopy images of probe-labeled cells and tissues were obtained with spectral confocal and multiphoton microscopes (Leica TCS SP8 MP) with a ×100 (NA = 1.30 OIL) and ×10 (NA = 0.30 DRY) objective lens, respectively. The two-photon fluorescence microscopy images were obtained with a DMI6000BMicroscope (Leica) by exciting the probes with a mode-locked titanium-sapphire laser source (Mai Tai HP; Spectra Physics, 80 MHz pulse frequency, 100 fs pulsewidth) set at wavelength 900 nm and output power 3050 mW, which corresponded to approximately 15mW average power in the focal plane. To obtain images at 400-600 nm range, internal PMTs were used to collect the signals in an 8 bit unsigned 512 × 512 pixels at 400 Hz scan speed.
Preparation and staining of fresh rat Hippocampal slices. Slices were prepared from the hippocampi of 2-weeks-old rat (SD). Coronal slices were cut into 400 μm-thick using a vibrating-blade microtome in artificial cerebrospinal fluid (ACSF; 124 mMNaCl, 3 mMKCl, 26 mM NaHCO 3 , 1.25 mM NaH 2 PO 4 , 10 mM D-glucose, 2.4 mM CaCl 2 , and 1.3 mM MgSO 4 ). Slices were incubated with 50 μMMNDA in ACSF bubbled with 95% O 2 and 5% CO 2 for 50min at 37 °C. Slices were then washed three times with ACSF and transferred to glass-bottomed dishes (MatTek) and observed in a spectral confocal multiphoton microscope. To assess the effect of NMM, the slices were treated with 200 μM of NMM for 30 min before MNDA was added.
Synthetic route of probe MNDA and FNDA Compound 3 was synthesized as described previously (M. Gravel, et al. Org. Lett., 2010, 12, 5772.) .
General
synthetic method for diethyl 6-substituent naphthalene-2,3-dicarboxylate (4) Triethylphosphine (2.8 mmol, 330 mg) was added dropwise to a CH 2 Cl 2 solution of diethylmaleate (2.6 mmol, 447 mg) with stirring at 0 °C under N 2 protection. The mixture was stirred at room temperature for 30 minutes. The above solution was added dropwise to a CH 2 Cl 2 solution of phthalaldehyde (2 mmol, 320 mg) with stirring at 0 °C. After completing the above addition, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) (0.2 mmol, 31 mg) was added to the mixture. The reaction was stirred for an additional 5 h and then washed with water and saturated NaCl solution. The organic layer was dried by anhydrous magnesium sulfate. The solvent was removed, and the residue was purified by column chromatography to obtain the desired compound as a colourless oil. Synthesis of (6-methoxynaphthalene-2,3-diyl) dimethanol (5)
A diisobutylaluminium hydride solution in 5 mL of toluene was slowly added to a toluene solution of diethyl 6-methoxynaphthalene-2,3-dicarboxylate (1 mmol, 302 mg) at -50°C under N 2 atmosphere. After the completion of the reaction, a saturated solution of sodium potassium tartarate was added, and the reaction mixture was extracted with ethyl acetate three times, followed by drying over anhydrous magnesium sulfate. The solvent was removed under reduced pressure, and the desired product was obtained as a white solid. 139.93, 137.91, 137.88, 133.27, 133.15, 130.67, 130.55, 129.59, 125.36, 124.66, 124.59, 116.08, 115.75, 110.96, 110.69, 60.90, 60.87 .
Synthesis of the substituent naphthalene-2,3-dicarbaldehyde
A solution of 5 mL of DMSO and 10 mL of CH 2 Cl 2 was added dropwise to a CH 2 Cl 2 solution of oxalyl chloride (3.5 mmol, 441 mg) with stirring at -78°C under N 2 . The resulting solution was stirred for an additional 30 minutes. Subsequently, a solution of (6-substituent naphthalene-2,3-diyl) dimethanol in the mixture of 5 mL of DMSO and 10 mL of CH 2 Cl 2 was added dropwise to the above mixture. Then, the reaction was stirred overnight and quenched with 5 mL of Et 3 N. Water was added, and the mixture was extracted with CH 2 Cl 2 , followed by drying over anhydrous magnesium sulfate. The solvent was removed, and the residue was purified by column chromatography to obtain the desired compound as a white solid. 193.53, 193.41, 164.28, 160.97, 135.87, 135.73, 134.21, 134.09, 133.45, 133.32, 132.85, 132.71, 132.64, 131.57, 120.71, 120.37, 113.68, 113.40 Figure S8 . HPLC-MS data of the probes' reactions with GSH, Hcy and Cys. 
